|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|||
|
Prevalence, Treatment, and Control of Combined Hypertension and Hypercholesterolemia in the United States |
Prevalencia, Tratamiento y Control de la Hipertensión Combinada con Hipercolesterolemia en los EE.UU. |
||
|
Hipertensión, hipercolesterolemia, prevalencia |
Hypertension, hypercholesterolemia, prevalence |
||
|
Wong ND, Lopez V, Tang S, Williams GR |
ND Wong, Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, University of California, Irvine, School of Medicine Irvine California EE.UU. |
||
|
Pfizer Pharmaceuticals |
Los autores no manifiestan conflictos de interés |
||
|
Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, University of California, School of Medicine |
|||
|
ReSIIC editado en las
especialidades: |
|||
|
|
|
|
|
Sociedad Iberoamericana de Información Científica (SIIC)
|